soul trial oral semaglutide cardiovascular outcomes nejm 2025 results found to lower risk of heart failure events in people with type 2 diabetes Oral Semaglutide Reduces CV Events

Synonyms: gestational diabetes mellitus ,

Mild to moderate nausea or passing feelings of stomach discomfort

A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type 2 diabetes and peripheral artery disease (PAD), particularly those at highest risk of amputation.

Brain fog often stems from blood sugar swings and metabolic dysfunction

Let's not ignore decades of positive data showing that statins prevent primary and secondary CVD, says Dr Kevin Fernando.

Clean, Safe & Quality GuaranteedAll of Nextdia high fiber gummies are manufactured, tested and bottled in a 3rd-party testing facility to ensure superior quality and consistency, they are Non-GMO, gelatin-free, gluten-free and vegan